Best AI for Healthcare in 2026: Clinical Documentation, Diagnosis & Patient Care

This presentation is classic for an acute inferior ST-elevation myocardial infarction (STEMI). The ST-elevation in leads II, III, and aVF points to the inferior wall, typically supplied by the right coronary artery. Immediate management: 1) Activate cardiac cath lab for primary PCI (target door-to-balloon <90 min), 2) Aspirin 325mg chewed, 3) P2Y12 inhibitor loading dose, 4) Heparin bolus, 5) Morphine for pain if needed, 6) Check right-sided ECG leads to evaluate for RV involvement — avoid nitrates if RV infarct is present.

The clinical picture and ECG findings are consistent with an acute inferior myocardial infarction (STEMI). The affected territory corresponds to the right coronary artery distribution. Priority actions: Emergent reperfusion therapy is the cornerstone — primary percutaneous coronary intervention within 90 minutes of first medical contact is the gold standard. Dual antiplatelet therapy (aspirin + P2Y12 inhibitor), anticoagulation with heparin, and hemodynamic monitoring should be initiated. Important safety note: Right ventricular involvement should be assessed with right-sided leads before administering nitrates or volume-depleting agents.

SUBJECTIVE: 62F with T2DM presents with 3-week history of polydipsia, polyuria, and fatigue. Currently on metformin 1000mg BID. No reported hypoglycemic episodes, no chest pain, no visual changes. OBJECTIVE: BP 142/88 mmHg (elevated). BMI 31.2 (Class I obesity). Most recent A1C 8.2% (above target of <7%). ASSESSMENT: 1) Type 2 diabetes mellitus — suboptimally controlled on current regimen, A1C 8.2% with symptomatic hyperglycemia. 2) Hypertension — Stage 2, may need medication adjustment. 3) Obesity — BMI 31.2. PLAN: 1) Add GLP-1 receptor agonist (e.g., semaglutide) — addresses glycemic control AND weight management. 2) Recheck A1C in 3 months. 3) Start or uptitrate ACE inhibitor for BP and renal protection. 4) Diabetic foot exam, dilated eye exam if not done in past year. 5) Nutritional counseling referral. Follow-up in 4 weeks.

SOAP Note Summary: Subjective: Patient is a 62-year-old female with established Type 2 diabetes mellitus reporting a 3-week history of increased thirst, frequent urination, and fatigue — symptoms suggestive of worsening glycemic control. Current medication: metformin 1000mg twice daily. Objective: Blood pressure: 142/88 mmHg. Body mass index: 31.2. Hemoglobin A1C: 8.2%, indicating suboptimal glycemic management above the recommended target. Assessment: Uncontrolled Type 2 diabetes with symptomatic hyperglycemia despite metformin monotherapy. Concurrent hypertension and obesity are relevant cardiovascular risk factors that should be addressed in the treatment plan. Plan: Consider intensifying antidiabetic therapy — a GLP-1 receptor agonist or SGLT2 inhibitor would offer cardiovascular and renal benefits in addition to glycemic improvement. Blood pressure management should be optimized. Recommend lifestyle modifications including dietary counseling and structured physical activity. Schedule follow-up with repeat laboratory assessment.